Betta Pharmaceuticals Statistics

Total Valuation

Betta Pharmaceuticals has a market cap or net worth of CNY 21.59 billion. The enterprise value is 23.19 billion.

Market Cap	21.59B
Enterprise Value	23.19B

Important Dates

The next estimated earnings date is Friday, April 18, 2025.

Earnings Date	Apr 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Betta Pharmaceuticals has 418.49 million shares outstanding. The number of shares has increased by 0.53% in one year.

Current Share Class	n/a
Shares Outstanding	418.49M
Shares Change (YoY)	+0.53%
Shares Change (QoQ)	+7.23%
Owned by Insiders (%)	3.78%
Owned by Institutions (%)	14.25%
Float	229.56M

Valuation Ratios

The trailing PE ratio is 47.37 and the forward PE ratio is 28.35. Betta Pharmaceuticals's PEG ratio is 0.94.

PE Ratio	47.37
Forward PE	28.35
PS Ratio	7.86
PB Ratio	3.83
P/TBV Ratio	6.28
P/FCF Ratio	69.49
P/OCF Ratio	n/a
PEG Ratio	0.94

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 30.97, with an EV/FCF ratio of 74.64.

EV / Earnings	50.46
EV / Sales	8.41
EV / EBITDA	30.97
EV / EBIT	57.04
EV / FCF	74.64

Financial Position

The company has a current ratio of 0.86, with a Debt / Equity ratio of 0.41.

Current Ratio	0.86
Quick Ratio	0.59
Debt / Equity	0.41
Debt / EBITDA	3.11
Debt / FCF	7.49
Interest Coverage	9.17

Financial Efficiency

Return on equity (ROE) is 8.03% and return on invested capital (ROIC) is 3.29%.

Return on Equity (ROE)	8.03%
Return on Assets (ROA)	2.79%
Return on Capital (ROIC)	3.29%
Revenue Per Employee	1.41M
Profits Per Employee	234,353
Employee Count	1,961
Asset Turnover	0.30
Inventory Turnover	1.56

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.81% in the last 52 weeks. The beta is 0.80, so Betta Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	+7.81%
50-Day Moving Average	51.92
200-Day Moving Average	41.53
Relative Strength Index (RSI)	42.59
Average Volume (20 Days)	5,900,055

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Betta Pharmaceuticals had revenue of CNY 2.76 billion and earned 459.57 million in profits. Earnings per share was 1.09.

Revenue	2.76B
Gross Profit	2.27B
Operating Income	406.58M
Pretax Income	462.11M
Net Income	459.57M
EBITDA	743.57M
EBIT	406.58M
Earnings Per Share (EPS)	1.09

Full Income Statement

Balance Sheet

The company has 816.38 million in cash and 2.33 billion in debt, giving a net cash position of -1.51 billion or -3.61 per share.

Cash & Cash Equivalents	816.38M
Total Debt	2.33B
Net Cash	-1.51B
Net Cash Per Share	-3.61
Equity (Book Value)	5.73B
Book Value Per Share	13.47
Working Capital	-250.33M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.19 billion and capital expenditures -874.88 million, giving a free cash flow of 310.70 million.

Operating Cash Flow	1.19B
Capital Expenditures	-874.88M
Free Cash Flow	310.70M
FCF Per Share	0.74

Full Cash Flow Statement

Margins

Gross margin is 82.20%, with operating and profit margins of 14.75% and 16.67%.

Gross Margin	82.20%
Operating Margin	14.75%
Pretax Margin	16.76%
Profit Margin	16.67%
EBITDA Margin	26.97%
EBIT Margin	14.75%
FCF Margin	11.27%

Dividends & Yields

This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 0.33%.

Dividend Per Share	0.17
Dividend Yield	0.33%
Dividend Growth (YoY)	142.86%
Years of Dividend Growth	1
Payout Ratio	31.34%
Buyback Yield	-0.53%
Shareholder Yield	-0.20%
Earnings Yield	2.11%
FCF Yield	1.44%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Betta Pharmaceuticals has an Altman Z-Score of 3.83.

Altman Z-Score	3.83
Piotroski F-Score	n/a